Effects of alprazolam on complex human functioning

Journal of Applied Social Psychology

Volumn 26, Issue 21, 1996, Pages 1912-1930

  Streufert, Siegfried ^a   Satish, Usha ^b   Pogash, Rosanne ^b   Gingrich, Dennis ^b   Landis, J Richard ^b   Lonardi, Lisa ^b   Miller, Jill ^b   Severs, Walter ^b   Roache, John D ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0030274340     PISSN: 00219029     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1559-1816.1996.tb00105.x     Document Type: Article

References (61)

1. Allen, D., Curran, H. V., & Lader, M. (1991). The effect of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects. European Journal of Clinical Pharmacology, 40, 355-362.
2. Barbee, J. G. (1993). Memory, benzodiazepines and anxiety: Integration of theoretical and clinical perspectives. Journal of Clinical Psychiatry, 54 (Suppl.), 86-97.
3. Barbee, J. G., Black, F. W., Kehoe, C. E., & Todorov, A. A. (1991). A comparison of single-dose effects of alprazolam, buspirone and placebo upon memory function. Journal of Clinical Psychopharmacology, 11, 351-356.
4. Barbee, J. G., Black, F. W., & Todorov, A. A. (1992). Differential effects of alprazolam and buspirone upon acquisition, retention and retrieval processes in memory. Journal of Neuropsychiatry and Clinical Neuroscience, 4, 308-314.
5. Bergman, H., Borg, S., & Holm, L. (1980). Neuropsychological impairment and exclusive abuse of sedatives or hypnotics. American Journal of Psychiatry, 137, 215-217.
6. Breuer, K., Streufert, S., & Nogami, G. Y. (in press). Personalentwicklung und auswahl mit diagnostischen simulationen (Personnel training and selection with diagnostic simulations). Goettingen, Germany: Hogrefe-Huber.
7. Cassano, G. B., Toni, C., Petracca, A., Deltito, J., Benkert, O., Curtis, G., Hippius, H., Maier, W., Shera, D., & Klerman, G. (1994). Adverse effects associated with the short term treatment of panic disorder with imipramine, alprazolam and placebo. European Neuropsychopharmacology, 4, 47-53.
8. Cole, J. O., & Kando, J. C. (1993). Adverse behavioral events reported in patients taking alprazolam and other benzodiazepines. Journal of Clinical Psychiatry, 54 (Suppl.), 49-61.
9. Crombez, G., Kupers, R., & Adriaensen, H. (1991). The effects of a single oral dose of lorazepam and alprazolam on reaction time in young healthy volunteers. Acta Anaesthesiologica Belgica, 42, 79-84.
10. Curran, H. V. (1986). Tranquilizing memories: A review of the effects of benzodiazepines on human memory. Biological Psychology, 23, 179-213.
11. Curran, H. V. (1991). Benzodiazepines, memory and mood: A review. Psychopharmacology, 105, 1-8.
12. Danjou, P., Warot, D., Hergueta, T., & Lacomblez, L. (1992). Comparative study of the psychomotor and antistress effects of ritanserin, alprazolam and diazepam in healthy subjects: Some trait-anxiety independent responses. International Clinical Psychopharmacology, 7, 73-79.
13. Derogatis, L. R. (1975). The SCL-90-R. Clinical Psychometrics Research. Baltimore, MD: Author.
14. DeVane, C. L., Ware, M. R., & Lydiard, R. B. (1991). Pharmacokinetics, pharmacodynamics and treatment issues of benzodiazepines: Alprazolam, adinazolam and clonazepam. Psychopharmacology Bulletin, 27, 463-473.
15. Ellinwood, E. H., Nikaido, A. M., Heatherly, D. G., & Bjornsson, T. D. (1987). Benzodiazepine pharmacodynamics: Evidence for biophase rate limiting mechanisms. Psychopharmacology, 91, 168-174.
16. Foltin, R. W., & Evans, S. M. (1993). Performance effects of drug abuse. Human Psychopharmacology, 8, 9-19.
17. Fromkin, H. L., & Streufert, S. (1976). Laboratory experimentation. In M. D. Dunette (Ed.), Handbook of industrial and organizational psychology (pp. 415-465). Chicago, IL: Rand McNally.
18. Ghoneim, M. M., & Mewaldt, S. P. (1990). Benzodiazepines and human memory: A review. Anesthesiology, 72, 926-938.
19. Golombok, S. (1989). Causes, effects and treatment of long-term benzodiazepine use: A review of psychological perspectives. Human Psychopharmacology - Clinical and Experimental, 4, 15-20.
20. Greenblatt, D. J., Harmatz, J. S., Dorsey, C., & Shader, R. I. (1988). Comparative single-dose kinetics and dynamics of lorazepam, alprazolam, prazepam and placebo. Clinical Pharmacology and Therapeutics, 44, 326-334.
21. Greenblatt, D. J., & Wright, C. E. (1993). Clinical pharmacokinetics of alprazolam. Clinical Pharmacokinetics, 24, 453-471.
22. Gudex, C. (1991). Adverse effects of benzodiazepines. Social Science and Medicine, 33, 587-596.
23. Haefely, W. (1990). The GABA-benzodiazepine interaction fifteen years later. Neurochemical Research, 15, 169-174.
24. Hendler, N., Cimini, C., Terence, M. A., & Long, D. (1980). A comparison of cognitive impairment due to benzodiazepines and to narcotics. American Journal of Psychiatry, 137, 830-838.
25. Hoehn-Sarie, R., McLeod, D. R., & Zimmerli, W. D. (1988). Differential aspects of alprazolam and imipramine in generalized anxiety disorder: Somatic vs. psychotic symptoms. Journal of Clinical Psychiatry, 49, 293-301.
26. Itil, T. M., Saletu, B., & Marasa, J. (1974). Determination of drug induced changes in sleep quality based on digital computer "sleep prints." Pharmacopsychiatry, 240, 265-280.
27. Jonas, J. M., & Cohon, M. S. (1993). A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic and depression: A review of the literature. Journal of Clinical Psychiatry, 54, 25-45.
28. Jones, M. B. (1970). A two-process theory of individual differences in motor learning. Psychological Review, 77, 353-360.
29. Jones, M. B. (1989). Individual differences in skill retention. American Journal of Psychology, 102, 183-196.
30. King, D. J. (1992). Benzodiazepines, amnesia and sedation: Theoretical and clinical issues and controversies. Human Psychopharmacology, 7, 79-87.
31. Kravitz, H. M., Fawcett, J., & Newman, A. J. (1993). Alprazolam and depression: A review of risks and benefits. Journal of Clinical Psychiatry (Suppl.), 78-85.
32. Kumar, R., Mac, D. S., Gabrielli, W. F., Jr., & Goodwin, D. W. (1987). Anxiolytics and memory: A comparison of lorazepam and alprazolam. Journal of Clinical Psychiatry, 48, 158-160.
33. Kunsman, G. W., Manno, J. E., Manno, B. R., Kunsman, C. M., & Przekop, M. A. (1992). The use of microcomputer-based psychomotor tests for the evaluation of benzodiazepine effects on human performance: A review with emphasis on temazepam. British Journal of Clinical Pharmacology, 34, 289-301.
34. Lader, M. (1990). Drug development optimization: Benzodiazepines. Agents and Actions, 29, 59-69.
35. Lin, K. M., Lau, J. K., Smith, R., Phillips, P., Antal, E., & Poland, R. E. (1988). Comparison of alprazolam plasma levels in normal Asian and Caucasian male volunteers. Psychopharmacololay, 96, 365-369.
36. Linnoila, M., Stapleton, J. M., Lister, R., Moss, H., Lane, E., Granger, A., & Eckardt, M. J. (1990). Effects of single doses of alprazolam and diazepam, alone and in combination with ethanol, on psychomotor and cognitive performance and on autonomic nervous system reactivity in healthy volunteers. European Journal of Clinical Pharmacology, 39, 21-28.
37. Lucki, I., Kerr, L. A., Fridman, R. B., Schweizer, E., & Rickels, K. (1989). Behavioral effects of alprazolam in chronic therapeutic users. NIDA Research Monograph, 95, 464.
38. McNair, D. M., Lorr, M., & Droppleman, L. S. (1971). Manual for the profile of moods states. San Diego, CA: Educational and Industrial Testing Service.
39. Miller, L. G., Greenblatt, D. J., Barnhill, J. G., & Shader, R. I. (1988). Chronic benzodiazepine administration: I. Tolerance is associated with benzodiazepine receptor downregulation and decreased y-aminobutyric acid receptor function. Journal of Pharmacology and Experimental Therapeutics, 246, 170-176.
40. Nikaido, A. M., Ellinwood, E. H., Heatherly, D. G., & Gupta, S. K. (1990). Age related increase in CNS sensitivity to benzodiazepines as assessed by task difficulty. Psychopharmacology, 100, 90-97.
41. Roth, T., & Roehrs, T. A. (1992). Issues in the use of benzodiazepine therapy. Journal of Clinical Psychiatry, 53 (Suppl.), 14-18.
42. Roy-Byme, P., Fleishaker, J., Arnett, C., & Dubach, M. (1993). Effects of acute and chronic alprazolam treatment on cerebral blood flow, memory, sedation, and plasma catecholamines. Neuropsychopharmacolgy, 8, 161-169.
43. Rush, C. R., Higgins, S. T., Bickel, W. K., & Hughes, J. R. (1993). Abuse liability of alprazolam relative to other commonly used benzodiazepines: A review. Neuroscience and Biobehavioral Reviews, 17, 277-285.
44. Salzman, C. (1993). Issues and controversies regarding benzodiazepine use. NIDA Research Monograph, 131, 68-88.
45. Selzer, M. L. (1971). The Michigan Alcoholism Screening Test: The quest for a new diagnostic instrument. American Journal of Psychiatry, 127, 89-94.
46. Shader, R. I., Dreyfuss, D., Gerrein, J. R., Harmatz, J. S., Allison, S. J., & Greenblatt, D. J. (1986). Sedative effects and impaired learning and recall following single oral doses of lorazepam. Clinical Pharmacological Therapy, 39, 526-529.
47. Shader, R. I., & Greenblatt, D. J. (1993). Use of benzodiazepines in anxiety disorders. The New England Journal of Medicine, 328, 1398-1405.
48. Simonsen, L. L. (1993, April). What are pharmacists dispensing most often? Pharmacy Times, 54, 29-44.
49. Streufert, S., DePadova, A., McGlynn, T., Pogash, R., & Piasecki, M. (1988). Impact of beta-blockade on complex cognitive functioning. American Heart Journal, 116, 311-318.
50. Streufert, S., & Gengo, F. M. (1993). Effects of drugs on human functioning. Basel, Switzerland: Karger.
51. Streufert, S., Pogash, R., Gingrich, D., Kantner, A., Lonardi, L., Severs, W., Landis, R., & Roache, J. (1993). Alcohol and complex functioning. Journal of Applied Social Psychology, 23, 847-866.
52. Streufert, S., Pogash, R., & Piasecki, M. (1988). Simulation based assessment of complex managerial performance: Reliability and validity. Personnel Psychology, 41, 537-557.
53. Streufert, S., Pogash, R., Roache, J., Gingrich, D., Landis, R., Severs, W., Lonardi, L., & Kantner, A. (1992). Effects of alcohol intoxication on risk taking strategy, and error rate in visuomotor performance. Journal of Applied Psychology, 77, 515-524.
54. Streufert, S., Pogash, R., Roache, J., Severs, W., Gingrich, D., Landis, R., Lonardi, L., & Kantner, A. (1994). Alcohol and managerial performance. Journal of Studies on Alcohol, 55, 230-238.
55. Streufert, S., Streufert, S. C., Denson, A. L., Lewis, J., Henderson, R., & Shields, J. L. (1984). Differential effects of work-related Stressors on cardiovascular responsivity. Stress and Anxiety, 9, 191-203.
56. Streufert, S., & Swezey, R. (1985). Simulation and related research methods in environmental psychology. In A. Baum & J. E. Singer (Eds.), Advances in environmental psychology (Vol. 5, pp. 99-117). Hillsdale, NJ: Lawrence Erlbaum.
57. Streufert, S., & Swezey, R. (1986). Complexity, managers and organizations. London, England: Academic.
58. Subhan, Z., Harrison, C., & Hindmarch, L. (1986). Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep. European Journal of Clinical Pharmacology, 29, 709-712.
59. Tata, P. R., Rollings, J., Collins, M., Pickering, A., & Jacobson, R. R. (1994). Lack of cognitive recovery following withdrawal from long-term benzodiazepine use. Psychological Medicine, 24, 203-213.
60. Woods, J. H., Katz, J. L., & Winger, G. (1992). Benzodiazepine use, abuse, and consequences. Pharmacology Review, 44, 151-347.
61. Zorumski, C. F., & Isenberg, K. E. (1991). Insights into the structure and function of GABA-benzodiazepine receptors: Ion channels and psychiatry. American Journal of Psychiatry, 148, 162-173.